David Lawrence, CFO of Valneva, was on Today on Radio 4 this morning. A minute or two after half seven, if anyone wants to listen to it.
He said they were going to report their first clinical data in the next couple of weeks, and anticipate submitting for approval in the autumn, by which time they will have vaccine doses available and ready to go. He anticipated no issues in adapting the vaccine for variants. The UK is at the front of the line for this.
He also said, "We have one key component we import from the United States" but they didn't anticipate issues. And "In the UK I suspect the Government would want us to complete the fill/finish in the UK, rather than our plant in Sweden. And that may cost a bit more. But if that's what the government require then obviously we'd sit round the table with them and work out a way to do that. And I think that's unfortunately where that might head."
So that's potentially one business lost from an EU country already. Well done, UvdL.